Epicentrx To Present Positive Phase 2A Clinical Data With Its Adapt-001 TGF-Β Trap Program In Checkpoint Inhibitor Resistant Patients At The 2024 AACR Meeting

  • Christopher Larson

Press/Media

Period2 Apr 2024

Media coverage

1

Media coverage

  • TitleEpicentrx To Present Positive Phase 2A Clinical Data With Its Adapt-001 TGF-Β Trap Program In Checkpoint Inhibitor Resistant Patients At The 2024 AACR Meeting
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date2/04/24
    PersonsChristopher Larson
View all 1
View less